248 related articles for article (PubMed ID: 32777161)
1. Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Smolle E; Leko P; Stacher-Priehse E; Brcic L; El-Heliebi A; Hofmann L; Quehenberger F; Hrzenjak A; Popper HH; Olschewski H; Leithner K
Mol Oncol; 2020 Nov; 14(11):2853-2867. PubMed ID: 32777161
[TBL] [Abstract][Full Text] [Related]
2. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.
Leithner K; Hrzenjak A; Trötzmüller M; Moustafa T; Köfeler HC; Wohlkoenig C; Stacher E; Lindenmann J; Harris AL; Olschewski A; Olschewski H
Oncogene; 2015 Feb; 34(8):1044-50. PubMed ID: 24632615
[TBL] [Abstract][Full Text] [Related]
3. Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?
Grasmann G; Smolle E; Olschewski H; Leithner K
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):24-36. PubMed ID: 31152822
[TBL] [Abstract][Full Text] [Related]
4. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
Vincent EE; Sergushichev A; Griss T; Gingras MC; Samborska B; Ntimbane T; Coelho PP; Blagih J; Raissi TC; Choinière L; Bridon G; Loginicheva E; Flynn BR; Thomas EC; Tavaré JM; Avizonis D; Pause A; Elder DJ; Artyomov MN; Jones RG
Mol Cell; 2015 Oct; 60(2):195-207. PubMed ID: 26474064
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway.
Hsu HP; Chu PY; Chang TM; Huang KW; Hung WC; Jiang SS; Lin HY; Tsai HJ
Cancer Med; 2023 Jan; 12(2):1588-1601. PubMed ID: 35757841
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell Growth.
Balsa-Martinez E; Puigserver P
Mol Cell; 2015 Nov; 60(4):509-11. PubMed ID: 26590709
[TBL] [Abstract][Full Text] [Related]
9. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Goodwin J; Neugent ML; Lee SY; Choe JH; Choi H; Jenkins DMR; Ruthenborg RJ; Robinson MW; Jeong JY; Wake M; Abe H; Takeda N; Endo H; Inoue M; Xuan Z; Yoo H; Chen M; Ahn JM; Minna JD; Helke KL; Singh PK; Shackelford DB; Kim JW
Nat Commun; 2017 May; 8():15503. PubMed ID: 28548087
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia increases the rate of renal gluconeogenesis via hypoxia-inducible factor-1-dependent activation of phosphoenolpyruvate carboxykinase expression.
Owczarek A; Gieczewska K; Jarzyna R; Jagielski AK; Kiersztan A; Gruza A; Winiarska K
Biochimie; 2020; 171-172():31-37. PubMed ID: 32045650
[TBL] [Abstract][Full Text] [Related]
11. PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells.
Bluemel G; Planque M; Madreiter-Sokolowski CT; Haitzmann T; Hrzenjak A; Graier WF; Fendt SM; Olschewski H; Leithner K
Free Radic Biol Med; 2021 Nov; 176():34-45. PubMed ID: 34520823
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis.
Xue S; Cai Y; Liu J; Ji K; Yi P; Long H; Zhang X; Li P; Song Y
Cell Signal; 2024 Apr; 120():111198. PubMed ID: 38697449
[TBL] [Abstract][Full Text] [Related]
13. Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters.
Koh YW; Lee SJ; Park SY
Lung Cancer; 2017 Feb; 104():31-37. PubMed ID: 28212997
[TBL] [Abstract][Full Text] [Related]
14. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M
Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability.
Méndez-Lucas A; Hyroššová P; Novellasdemunt L; Viñals F; Perales JC
J Biol Chem; 2014 Aug; 289(32):22090-102. PubMed ID: 24973213
[TBL] [Abstract][Full Text] [Related]
17. Pck-ing up steam: Widening the salmonid gluconeogenic gene duplication trail.
Marandel L; Kostyniuk DJ; Best C; Forbes JLI; Liu J; Panserat S; Mennigen JA
Gene; 2019 May; 698():129-140. PubMed ID: 30849535
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
[TBL] [Abstract][Full Text] [Related]
19. Intricate Regulation of Phosphoenolpyruvate Carboxykinase (PEPCK) Isoforms in Normal Physiology and Disease.
Seenappa V; Joshi MB; Satyamoorthy K
Curr Mol Med; 2019; 19(4):247-272. PubMed ID: 30947672
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors.
Chu PY; Jiang SS; Shan YS; Hung WC; Chen MH; Lin HY; Chen YL; Tsai HJ; Chen LT
Oncotarget; 2017 Nov; 8(61):103613-103625. PubMed ID: 29262588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
